Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia

Microbiological Reviews

Volumn 60, Issue 3, 1996, Pages 539-574

  Govan, J R W ^a   Deretic, V ^b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; ERRATUM; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA;

EID: 0029814366     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.60.3.539-574.1996     Document Type: Erratum

References (506)

1. Agnarsson, U., S. Glass, and J. R. W. Govan. 1989. Fecal isolation of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 27:96-98.
2. Al-Awqati, Q., J. Barasch, and D. Landry. 1992. Chloride channels of intracellular organelles and their potential role in cystic fibrosis. J. Exp. Biol. 172:245-266.
3. Allison, D. G., and M, J. Goldsbrough. 1994. Polysaccharide production in Pseudomonas cepacia, J. Basic Microbiol. 34:3-10.
4. Ames, P., D. DesJardins, and G. B. Pier. 1985. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide. Infect. Immun. 49:281-285.
5. Anastassiou, E. D., A. C. Mintzas, C. Kounavis, and G. Dimitraiopoulos, 1987. Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains. J. Clin. Microbiol. 25:656-659.
6. Anderson, A. J., A. J. Hacking, and E. A. Dawes. 1987. Alternative pathways for the biosynthesis of alginate from fructose and glucose in Pseudomonas mendocina and Azotobacter vinelandii. J. Gen. Microbiol. 133:1045-1052.
7. Anonymous. 1992. Pseudomonas cepacia - more than a harmless commensal? Lancet 339:1385-1386. (Editorial.)
8. Anwar, H., M. R. W. Brown, and P. A. Lambert. 1983. Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytic and serum bactericidal activity at different temperatures. J. Gen. Microbiol. 129:2021-2027.
9. Anwar, H., J. L. Strap, and J. W. Costerton. 1992. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 36:1347-1351.
10. Aoki, M., K. Uehara, K. Koseki, K. Tsuji, K. Ono, and M. Iijima. 1993. Large scale culture and preservation methods of Pseudomonas cepacia B5 for biological control against bacterial wilt disease. Biosci. Biotechnol. Biochem. 57:668-669.
11. Armstrong, D. S., K. Grimwood, R. Carzino, J. B. Carlin, A. Olinsky, and P. D. Phetan. 1995. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br. Med. J. 310:1571-1572.
12. Aronoff, S. C., F. J. Quinn, and R. C. Stern. 1991. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Pediatr. Pulmonol. 11:289-293.
13. Association of Cystic Fibrosis Adults (UK). 1993. Cystic fibrosis statement on Pseudomonas cepacia. Newsl. Assoc. Cystic Fibrosis Adults 37:2-5.
14. Baker, N. R. 1990. Adherence and the role of alginate, p. 95-108. In P. Gacesa and N. J. Russell (ed.), Pseudomonas infection and alginates. Chapman & Hall Ltd., London.
15. Baker, N. R., and C. Svanborg-Eden. 1989. Role of alginate in the adherence of Pseudomonas aeruginosa. Antibiot. Chemother. 42:72-79.
16. Baltimore, R. S., and M. Mitchell. 1980. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceplibility to opsonic antibody in mucoid and nonmucoid strains. J. Infect. Dis. 141:238-247.
17. Baltimore R. S., and D. G. Shedd. 1983. The role of complement in the opsonization of mucoid and nun-mucoid strains of Pseudomonas aeruginosa. Pediatr. Res. 17:952-958.
18. Barasch, J., B. Kiss, A. Prince, L. Saiman, D. Gruinert, and Q. Al-Awqati. 1991. Defective acidification of intracellular organelles in cystic fibrosis. Nature (London) 352:70-73.
19. Barton, A. D., K. Ryder, R. V. Lourenco, W. Dralle, and S. G. Weiss. 1976. Inflammatory rection and airway damage in cystic fibrosis. J. Lab. Clin. Med. 88:423-426.
20. Bayer, A. S., F. Eftekhar, J. Tu, C. C. Nast, and D. Speert. 1990. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa. Infect. Immun. 58:1344-1349.
21. Bayer, A. S., D. P. Speert, S. Park, J. Tu, M. Witt, C. C. Nast, and D. C. Norman. 1991. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Infect. Immun. 59:302-308.
22. Beckman, W., and T. G. Lessie. 1979. Response of Pseudomonas cepacia to β-lactam antibiotics: utilization of penicillin G as the carbon source. J. Bacteriol. 140:1126-1128.
23. Bedard, M., C. D. McClure, N. L. Schiller, C. Francoeur, A. Cantin, and M. Denis. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell. Mol. Biol. 9:455-462.
24. Bender, J. G., A. L. Florman, and D. E. van Epps. 1987. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by netrophil super-oxide anion generation. Pediatr. Res. 22:383-388.
25. Benson, A. K., and W. G. Haldenwang. 1993. Bacillus subtilis sigma B is regulated by a binding protein (RsbW) that blocks its association with core RNA polymerase Proc. Natl. Acad. Sci. USA 90:2230-2334.
26. Berry, A., J. D. DeVault, and A. M. Chakrabarty. 1989. High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J. Bacteriol. 171:2312-2317.
27. Bevivino, A., S. Tabacchioni, L. Chiarni, M. V. Carusi, M. del Gallo, and P. Visca. 1994. Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia. Microbiology 140:1069-1077.
28. Bingen, E., K. Botzenhart, G. Chabanon, G. Döring, J. Govan, N. Høiby, J. J. LiPuma, Y. Michel-Briand, J. Ogle, U. Römling, A. Smith, D. Speert, R. Stern, O. Tablan, and C. Wolz. 1993. Epidemiology of pulmonary infections by Pseudomonas in patients with cystic fibrosis: a consensus report. French Cystic Foundation Association (AFLM). Paris.
29. Birrer, P., N. G. McElvaney, A. Ruderberg, C. Wirz Sommer, S. LeichtiGallati, R. Kraemer, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
30. Boat, T. F., M. J. Welsh, and A. L. Beaudet. 1989. Cystic fibrosis, p. 2649-2680. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic basis of inherited disease, II. McGraw-Hill Book Co., New York.
31. Bottone, E. J., S. D. Douglas, A. R. Rausen, and G. T. Keusch. 1975. Association of Pseudomonas cepacia with chronic granulomatous disease. J. Clin. Microbiol. 1:425-428.
32. Botzenhart, K., and G. Döring. 1993. Ecology and epidemiology of Pseudomonas aeruginosa, p. 1-13. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York.
33. Boucher, J. C., J. Martinez-Salazar, M. J. Schurr, M. Mudd, H. Yu, and V. Deretic. 1996. Two distinct loci affecting conversion to mucoidy in cystic fibrosis encode homologs of the serine protease HtrA. J. Bacteriol. 178: 511-523.
34. Boyd, A., and A. M. Chakrabarty. 1994. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 60:2355-2359.
35. Boyd, A., M. Ghosh, T. B. May, D. Shinaberger, R. Koegh, and A. M. Chakrabarty. 1993. Sequence of the algL gene of Pseudomonas aeruginosa and purification of its alginate lyase product. Gene 131:1-8.
36. Brown, K. L., and K. T. Hughes. 1995. The role of anti-sigma factors in gene regulation. Mol. Microbiol. 16:397-404.
37. Brown, M. A., W. J. Morgan, P. R. Finley, and P. Scuderi. 1991. Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis. Pediatr. Pulmonol. 10:86-91.
38. Brown, M. R. W., H. Anwar, and P. Lambert. 1984. Evidence that mucoid Pseudomonas aeruginosa in the CF lung grows under iron-restricted conditions. FEMS Microbiol. Lett. 21:113-117.
39. Brown, P., S. Butler, J. Nelson, C. Doherty, J. Govan, and A. Greening. 1993. Pseudomonas cepacia in adult cystic fibrosis: accelerated decline in lung function and increased mortality. Thorax 48:425-426.
40. Bukau, B. 1993. Regulation of the Escherichia coli heat-shock response. Mol. Microbiol. 9:671-680.
41. Bukovits, G. J., N. Mohr, H. Budziewicz, H. Korth, and G. Pulverer. 1982. 2-Phenyl thiazole derivatives from Pseudomonas cepacia. Z. Naturforsch. Teil B 37:877-880.
42. Bullock, G. L. 1965. Characteristics and pathogenicity of a capsulated Pseudomonas isolated from a goldfish. Appl. Microbiol. 13:89-92.
43. Burdge, D. R., E. M. Nakielna, and M. A. Noble. 1993. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect. Control Hosp. Epidemiol. 14:127-130.
44. Burkholder, W. H. 1950. Sour skin, a bacterial rot of onion bulbs. Phyto-pathology 40:115-117.
45. Burnie, J. P., E. J. Al-Wardi, P. Williamson, R. C. Matthews, K. Webb, and T. David. 1995. Defining potential targets for immunotherapy in Burkholderia cepacia infection. FEMS Immunol. Med. Microbiol. 10:157-164.
46. Burns, J. L. 1992. Characterization of invasion of epithelial cells by Pseudomonas cepacia. Pediatr. Pulmonol. 8(Suppl. 8):201. (Abstract.)
47. Burns, M. W., and J. R. May. 1968. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet i:270-272.
48. Butler, S. L. 1994. Pulmonary colonisation of patients with cystic fibrosis by Burkholderia cepacia. Ph.D. thesis. University of Edinburgh, Edinburgh, Scotland.
49. Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
50. Butler, S. L., J. W. Nelson, and J. R. W. Govan. 1992. Cell surface characteristics of Pseudomonas cepacia isolates from patients with cystic fibrosis, abstr. TP8. In Proceedings of the XIth International Cystic Fibrosis Congress. Irish Cystic Fibrosis Foundation, Dublin.
51. Butler, S. L., J. W. Nelson, I. R. Poxton, and J. R. W. Govan. 1994. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 8:285-292.
52. Bye, M. R., J. M. Ewig, and L. M. Quittell. 1994. Cystic fibrosis. Lung 172:251-270.
53. Cabrai, D. A., B. A. Loh, and D. P. Speert. 1987. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Paediatr. Res. 22:429-431.
54. Cameron, R. M., K. Stevenson, N. F. Inglis, J. Klausen, and J. M. Sharp. 1994. Identification and characterization of a putative serine protease expressed in vivo by Mycobacterium avium subsp. paratuberculosis. Microbiology 140:1977-1994.
55. Caplen, N. J., E. W. F. W. Alton, P. G. Middleton, J. R. Dorin, B. J. Stevenson, X. Gao, S. R. Durham, P. K. Jeffery, M. E. Hodson, C. Coutelle, L. Huang, D. J. Porteous, R. Williamson, and D. M. Geddes. 1995. Lipo-some-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1:39-46.
56. Carson, L. A., M. S. Favero, W. W. Bond, and N. J. Petersen, 1973. Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl. Microbiol. 25:476-483.
57. Ceri, H., H. A. I. McArthur, and C. Whitfield. 1986. Association of alginate from Pseudomonas aeruginosa with two forms of heparin-binding lectin isolated from rat lung. Infect. Immun. 51:1-5.
58. Cetin, E. T., K. Toreci, and Ö. Ang. 1965. Encapsulated Pseudomonas aeruginosa (Pseudomonas aeruginosa mucosus) strain. J. Bacteriol. 89:1432-1433.
59. Cheng, H.-P., and T. G. Lessie. 1994. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J. Bacteriol. 176:4034-4042.
60. Chi, E., and D. H. Bartlett. 1995. An rpoE-like locus controls outer membrane protein synthesis and growth at cold temperatures and high pressures in the deep-sea bacterium Photobacterium sp. strain SS9. Mol. Microbiol. 17:713-726.
61. Chitnis, C. E., and D. E. Ohman. 1990. Cloning of Pseudomonas aeruginosa algG, which controls alginate structure. J. Bacteriol. 172:2894-2900.
62. Chitnis, C. E., and D. E. Ohman. 1993. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence for an operonic structure. Mol. Microbiol. 8:583-590.
63. Christenson, J. C., D. F. Welch, G. Mukwaya, M. J. Muszynski, R. E. Weaver, and D. J. Brenner. 1989. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J. Clin. Microbiol. 27:270-273.
64. Chu, L., T. B. May, A. M. Chakrabarty, and T. K. Misra. 1991. Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Gene 107:1-10.
65. Cimolai, N., and C. Trombley. 1995. Insertional sequence primers for Bordetella pertussis diagnostic polymerase chain reaction differentiate strains of Pseudomonas cepacia. J. Infect. Dis. 172:293-295.
66. Conti, E., A. Flaibani, M. O'Regan, and I. W. Sutherland. 1994. Alginate from Pseudomonas fluorescens and P. putida: production and properties. Microbiology 140:1125-1132.
67. 2 on in vitro susceptibility of Pseudomonas cepacia to β-lactams. Pediatr. Res. 35:299-302.
68. Costerton, J. W., M. R. W. Brown, J. Lam, K. Lam, and D. M. G. Cochrane. 1990. The microcolony mode of growth in vivo - an ecological perspective. p. 76-94. In P. Gacesa and N. J. Russell (ed.), Pseudomonas infection and alginates. Chapman and Hall Ltd., London.
69. Costerton, J. W., K.-J. Cheng, G. G. Geesey, T. I. Ladd, J. C. Nickel, M. Dasgupta, and T. J. Marrie. 1987. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41:435-464.
70. Coyne, M. J., Jr., K. S. Russell, C. L. Coyle, and J. B. Goldberg. 1994. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J. Bacteriol. 176: 3500-3507.
71. Crokaert, F., M.-J. Lismont, M.-P. van der Linden, and E. Yourassowsky. 1992. Determination of complement mediated serum bactericidal activity against gram-negative bacteria. Rev. Med. Microbiol. 3:241-247.
72. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C.-S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42-51.
73. Dahr, P., and H. Kolb. 1935. Schleimige-Bakterienwuchsform als Krankheitserreger. Dtsch. Med. Wochenschr. 61:1879-1881.
74. Dailey, R. H., and E. J. Benner. 1968. Necrotizing pneumonitis due to the pseudomonad "Eugonic oxidiser-group 1." N. Engl. J. Med. 279:361-362.
75. Daley, L., G. B. Pier, J. D. Liporace, and D. D. Eardley. 1985. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J. Immunol. 134:3089-3093.
76. Darzins, A., and A. M. Chakrabarty. 1984. Cloning of genes controlling alginate biosynthesis from mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J. Bacteriol. 159:9-18.
77. Darzins, A., B. Frantz, R. I. Vanags, and A. M. Chakrabarty. 1986. Nucleotide sequence analysis of the phosphomannose isomerase gene (pmi) of Pseudomonas aeruginosa and comparison with the corresponding Escherichia coli manA gene. Gene 42:293-302.
78. Darzins, A., L. L. Nixon, R. I. Vanags, and A. M. Chakrabarty. 1985. Cloning of Escherichia coli and Pseudomonas aeruginosa phosphomannose isomerase genes and their expression in alginate-negative mutants of Pseudomonas aeruginosa. J. Bacteriol. 1651:249-257.
79. Darzins, A., S. K. Wang, R. I. Wanags, and A. M. Chakrabarty. 1985. Clustering of mutations affecting alginic acid biosynthesis in mucoid Pseudomonas aeruginosa. J. Bacteriol. 164:516-524.
80. Dasen, S. E., J. J. LiPuma, J, R. Kostman, and T. L. Stull. 1994. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J. Clin. Microbiol. 32:2422-2424.
81. Davidson, D. J., J. R. Dorin, G. McLachlan, V. Ranaldi, D. Lamb, C. Doherty, J. Govan, and D. J. Porteous. 1995. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat. Genet. 9:351-357.
82. Davies, D. G., and G. G. Geesey. 1995. Regulation of the alginate biosynthetic gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61:860-867.
83. Davison, J. 1988. Plant beneficial bacteria. Bio/Technology 6:282-285.
84. DeFreitas, J. R., and J. J. Germida. 1991. Pseudomonas cepacia and Pseudomonas putida as winter wheat inoculants for biocontrol of Rhizoctonia solani. Can. J. Microbiol. 37:780-784.
85. Deretic, V. 1995. Signal transduction and environmental stress in control of Pseudomonas aeruginosa virulence, p. 43-50. In R. Rappuoli, V. Scarlato, and B. Arico (ed.), Signal transduction and bacterial virulence. Landes, Austin, Tex.
86. Deretic, V. Molecular biology of mucoidy in Pseudomonas aeruginosa. In J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis current topics, vol. 3, in press. John Wiley & Sons, Ltd., Chichester, England.
87. Deretic, V., R. Diksit, W. M. Konyecsni, T. Misra, A. M. Chakrabarty, and T. K. Misra. 1989. The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes. J. Bacteriol. 171:1278-1283.
88. Deretic, V., J. F. Gill, and A. M. Chakrabarty. 1987. Gene algD coding for GDOmannose dehydrogenase is transcriptionally activated in mucoid Pseudomonas aeruginosa. J. Bacteriol. 169:351-358.
89. Deretic, V., J. F. Gill, and A. M. Chakrabarty. 1987. Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res. 15:4567-4581.
90. Deretic, V., J. R. W. Govan, W. M. Konyecsni, and D. W. Martin. 1990. Mucoid Pseudomonas aeruginosa in cystic fibrosis: mutations in the mue loci affect transcription of the algR and algD genes in response to environmental stimuli. Mol. Microbiol. 4:189-196.
91. Deretic, V., N. S. Hibler, and S. C. Holt. 1992. Immunochemical analysis of AlgP(Hp1), a histonelike element participating in control of mucoidy in Pseudomonas aeruginosa. J. Bacteriol. 174:824-831.
92. Deretic, V., and W. M. Konyecsni. 1989. Control of mucoidy in Pseudomonas aeruginosa: transcriptional regulation of algR and identification of the second regulatory gene, algQ. J. Bacteriol. 171:3680-3688.
93. Deretic, V., D. W. Martin, M. J. Schurr, M. H. Mudd, R. Curcic, and J. C. Boucher. 1993. Conversion to mucoidy in Pseudomonas aeruginosa. Bio/ Technology 11:1133-1136.
94. Deretic, V., C. D. Mohr, and D. W. Martin. 1991. Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence. Mol. Microbiol. 5:1577-1583.
95. Deretic, V., M. J. Schurr, J. C. Boucher, and D. W. Martin. 1994. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176:2773-2780.
96. Deretic, V., M. J. Schurr, and H. Yu. 1995. Pseudomonas aeruginosa, mucoidy and chronic infection phenotype in cystic fibrosis. Trends Microbiol. 3:351-356.
97. DeVault. J. D., W. Hendrickson, J. Kato, and A. M. Chakrabarty. 1991. Environmentally regulated algD promoter is responsive to the cAMP receptor protein in Escherichia coli. Mol. Microbiol. 5:2503-2509.
98. DeVault, J. D., K. Kimbara, and A. M. Chakrabarty. 1990. Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aerugi-nosa. Mol. Microhiol. 4:737-745.
99. DeVries, C. A., and D. E. Ohman. 1994. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontanous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176:6677-6687.
100. Diaz, F., L. L. Mosovich, and E. Neter. 1970. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis. J. Infect. Dis. 121:269-274.
101. Di Sant'Agnese, P. A., and D. H. Andersen. 1946. Celiac syndrome: chemotherapy in infections of the respiratory tract associated with cystic fibrosis of the pancreas: observations with penicillin and drugs of the sulphonamide groups, with special reference to penicillin aerosol. Am. J. Dis. Child. 72:17-61.
102. Doggett, R. G. 1969. Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Appl. Microbiol. 18:936-937.
103. Doggett, R. G., G. M. Harrison, R. N. Stillwell, and E. S. Wallis. 1966. An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas. J. Pediatr. 68:215-221.
104. Doggett, R. G., G. M. Harrison, and E. S. Wallis. 1964. Comparison of some properties of Pseudomonas aeruginosa isolated from infections in persons with and without cystic fibrosis. J. Bacteriol. 87:427-431.
105. Doig, P., N. R. Smith, T. Todd, and R. T. Irvin. 1987. Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect. Immun. 55:1517-1522.
106. Dorin, J. R., P. Diekinson, E. W. F. W. Alton, S. N. Smith, D. M. Geddes, B. J. Stevenson, W. L. Kimber, S. Fleming, A. R. Clarke, M. L. Hooper, L. Anderson, R. S. P. Beddington, and D. J. Porteous. 1992. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (London) 359:211-214.
107. During, G. 1994. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care. Med. 150(Suppl.):S114-S117.
108. Döring, G., H. Bareth, A. Gairing, C. Wolz, and K. Botzenhart. 1989. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets. Epidemiol. Infect. 103:555-564.
109. Dosanjh, A., W. Lencer, D. Brown, D. A. Ausiello, and J. L. Stow. 1994. Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates. Am. J. Physiol. 266:C360-C366.
110. Drumm, M. L., H. A. Pope, W. H. Cliff, J. M. Rommens, S. A. Marvin, L.-C. Tsui, F. S. Collins, R. A. Frizzel, and J. M. Wilson. 1990. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62:1227-1233.
111. H). J. Bacteriol, 170:1054-1062.
112. E from Bacillus subtilis. Proc. Natl. Acad. Sci. USA 90:2325-2329.
113. Ederer, G. M., and J. M. Matsen. 1972. Colonization and infection with Pseudomonas cepacia. J. Infect. Dis. 125:613-618.
114. Elborn, J. S., M. Dodd, J. Maddison, L. E. Nixon, J. Nelson, J. Govan, A. K. Webb, and D. J. Shale. 1994. Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Pulmonol. 10(Suppl.):287.
115. Elston, H. R., and K. C. Hoffman. 1967. Increasing incidence of encapsulated Pseudomonas aeruginosa strains. Am. J. Clin. Pathol. 48:519-523.
116. Elzer, P. H., R. W. Phillips, M. E. Kovach, K. M. Peterson, and R. M. Roop II. 1994. Characterization and genetic complementation of a Brucella abortus high-temperature-requirement A (htrA) deletion mutant. Infect. Immun. 62:4135-4139.
117. Engelhardt, J. F., J. R. Vankaskas, S. A. Ernst, Y. Yang, C. R. Marino, R. C. Boucher, J. A. Cohn, and J. M. Wilson. 1992. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2:240-248.
118. Erickson, J. W., and C. A. Gross. 1989. Identification of the subunit of Escherichia coli RNA polymerase: a second alternate factor involved in high-temperature gene expression. Genes Dev. 3:1462-1471.
119. Erickson, J. W., V. Vaughn, W. A. Walter, F. C. Neidhardt, and C. A. Gross. 1987. Regulation of the promoters and transcripts of rpoH, the Escherichia coli heat shock regulatory gene. Genes Dev. 1:419-432.
120. Ertesvag, H., H. K. Hoidal, I. K. Hals, A. Rian, B. Doseth, and S. Valla. 1995. A family of modular type mannuronan C-5-epimerase genes controls alginate structure in Azotobacter vinelandii. Mol. Microbiol. 16:719-731.
121. Evans, D. J., G. B. Pier, M. J. Coyne, Jr., and J. B. Goldberg. 1994. The rbf locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol. Microbiol. 13:427-434.
122. Evans, L. R., and A. Linker. 1973. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J. Bacteriol. 116:915-924.
123. Fialho, A. M., N. A. Zielinski, W. F. Fett, A. M. Chakrabarty, and A. Berry. 1990. Distribution of alginate gene sequences in the Pseudomonas rRNA homology group I-Azomonas-Azotobacter lineage of superfamily B procaryotes. Appl. Environ. Microbiol. 56:436-443.
124. Fisher, M. C., J. J. LiPuma, S. E. Dasen, G. C. Caputo, J. E. Mortensen, K. L. McGowan, and T. L. Stull. 1993. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J. Pediatr. 123:745-747.
125. Fitzsimmons, S. C. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1-9.
126. Fleishmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J.-F. Tomb, B. A. Doughetry, J. M. Merrick, K. McKeenney, G. Sutton, W. FitzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L.-I. Lieu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman. J. L. Fuhrmann, N. S. M. Georghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenae Rd. Science 269:496-512.
127. Flynn, J. L., and D. E. Ohman. 1988. Use of gene replacement cosmid vector for cloning alginate conversion geens from mucoid and nonmucoid Pseudomonas aeruginosa strains: algS controls expression of algT. J. Bacteriol. 170:3228-3236.
128. Flynn, .T. L., and D. E. Ohman. 1988. Cloning of genes from mucoid Pseudomonas aeruginosa which control spontaneous conversion to the alginate producing phenotype. J. Bacteriol. 170:1352-1460.
129. Folsom, B. R., P. J. Chapman, and P. H. Pritchard. 1990. Phenol and trichloroethylene degradation by Pseudomonas cepacia G4: kinetics and interactions between substrates. Appl. Environ. Microbiol. 56:1279-1285.
130. Franklin, M. J., C. E. Chitnis, P. Gacesa, A. Sonesson, D. C. White, and D. E. Ohman. 1994. Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan epimerase. J. Bacteriol. 176:1821-1830.
131. Franklin, M. J., and D. E. Ohman. 1993. Identification of algF in the alginate biosynthetic gene cluster of Pseudomonas aeruginosa which is required for alginate acetylation. J. Bacteriol. 175:5057-5065.
132. Franklin, M. J., and D. E. Ohman. 1996. Identification of algl and algJ in the Pseudomonas aeruginosa biosynthetic gene cluster which are required for alginate O acetylation. J. Bacteriol. 178:2186-2195.
133. Fridlander, M., J. Inbar, and I. Chet. 1993. Biological control of soil-borne plant pathogens by a beta-1,3 glucanase-producing Pseudomonas cepacia. Soil Biol. Biochem. 25:1211-1221.
134. Friend, P. A., and S. W. B. Newsom. 1986. Hygiene for hydrotherapy pools. J. Hosp. Infect. 8:213-216.
135. Fujiwara, S., N. A. Zielinski, and A. M. Chakrabarry. 1993. Enhancer-like activity of AlgR1-binding site in alginate gene activation; positional, orientational, and sequence specificity. J. Bacteriol. 175:5452-5459.
136. Fyfe, J. A. M., and J. R. W. Govan. 1980. Alginate sythesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J. Gen. Microbiol. 119:443-450.
137. Fyfe, J. A. M., and J. R. W. Govan. 1983. Synthesis, regulation and biological function of bacterial alginate. Prog. Ind. Microbiol. 18:45-83.
138. Fyfe, J. A. M., and J. R. W. Govan. 1984. Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa. J. Gen. Microbiol. 130:825-834.
139. Gabriel, S. E., K. N. Brigman, B. H. Koller, R. C. Boucher, and M. J. Stutts. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266:107-109.
140. Gacesa, P., and N. J. Russell. 1990. The structure and properties of alginate, p. 29-49. In P. Gacesa and N. J. Russell (ed.), Pseudomonas infections and alginates: biochemistry, genetics and pathology. Chapman & Hall Ltd., London.
141. Garner, C. V., D. DesJardins, and G. B. Pier. 1990. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide. Infect. Immun. 58:1835-1842.
142. Gessner, A. R., and J. E. Mortensen. 1990. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J. Med. Microbiol. 33:115-120.
143. Gill, J. F., V. Deretic, and A. M. Chakrabarty. 1986. Overproduction and assay of Pseudomonas aeruginosa phosphomannose isomerase. J. Bacteriol. 167:611-615.
144. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
145. Gilligan, P. H., P. A. Gage, L. M. Bradshaw, D. V. Schidlow, and B. T. DeCicco. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 22:5-8.
146. Gladman, G., P. J. Connor, R. F. Williams, and T. J. David. 1992. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch. Dis. Child. 67:192-195.
147. Glass, S., and J. R. W. Govan. 1986. Pseudomonas cepacia - fatal pulmonary infection in a patient with cystic fibrosis. J. Infect. 13:157-158.
148. Godard, C., P. Plesiat, and Y. Michel-Briand. 1993. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur. J. Med. 2:117-120.
149. Goldberg, J. B., M. J. Coyne, A. N. Neely, and I. A. Holder. 1995. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect. Immun. 63:4166-4169.
150. Goldberg, J. B., and T. Dahnke. 1992. Pseudomonas aeruginosa AlgB, which modulates the expression of alginate, is a member of NtrC subclass of prokaryotic regulators. Mol. Microbiol. 6:59-66.
151. Goldberg, J. B., W. L. German, J. Flynn, and D. E. Ohman. 1993. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J. Bacteriol. 175:1303-1308.
152. Goldberg, J. B., K. Hatano, G. S. Meluleni, and G. B. Pier. 1992. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc. Natl. Acad. Sci. USA 89:10616-10720.
153. Goldberg, J. B., K. Hatano, and G. B. Peir. 1993. Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomulase. J. Bacteriol. 175:1605-1611.
154. Goldberg, J. B., and D. E. Ohman. 1984. Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J. Bacteriol. 158:1115-1121.
155. Goldberg, J. B., and D. E. Ohman. 1987. Construction and characterization oi Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate. J. Bacteriol. 169:1593-1602.
156. Goldman, D. A., and J. D. Klinger. 1986. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J. Pediatr. 108:806-812.
157. Goldstein, R., L. Sun, R.-Z. Jiang, U. Sajjan, J. F. Forstner, and C. Campanelli. 1995. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J. Bacteriol. 177:1039-1052.
158. Gonzalez, C. F., and A. K. Vidaver. 1979. Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin. J. Gen. Microbiol. 110:161-170.
159. Govan, J. R. W. 1975. Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J. Med. Microbiol. 8:513-522.
160. Govan, J. R. W. 1988. Alginate biosynthesis and other unusual characteristics associated with the pathogenesis of Pseudomonas aeruginosa in cystic fibrosis, p. 67-96. In E. Griffiths, W. Donachie, and J. Stephen (ed.), Bacteriol infections of respiratory and gastrointestinal mucosae. IRL Press, Oxford.
161. Govan, J. R. W. 1989. Pseudomonas, p. 491-504. In 1. G. Collee, A. G. Fraser, B. P. Marmion, and A. Simmon (ed.), Practical medical microbiology. 14th ed. Churchill Livingstone Ltd., Edinburgh.
162. Govan, J. R. W. 1995. Burkholderia cepacia in cystic fibrosis. N. Engl. J. Med. 332:819-820. (Letter.)
163. Govan, J. R. W. Unpublished results.
164. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
165. Govan, J. R. W., C. Doherty, and S. Glass. 1987. Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection 15:300-307.
166. Govan, J. R. W., and J. A. M. Fyfe. 1978. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J. Antimicrob. Chemother. 4:233-240.
167. Govan, J. R. W., J. A. M. Fyfe, and T. R. Jarman. 1981. Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida, and Pseudomonas mendocina. J. Gen. Microbiol. 125:217-220.
168. Govan, J. R. W., J. A. M. Fyfe, and C. McMillan. 1979. The instability of mucoid Pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J. Gen. Microbiol. 110:229-232.
169. Govan, J. R. W., and S. Glass. 1990. The microbiology and therapy of cystic fibrosis lung infection. Rev. Med. Microbiol. 1:19-28.
170. Govan, J. R. W., and G. Harris. 1985. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J. Clin Microbiol. 22:490-494.
171. Govan, J. R. W., and G. S. Harris. 1986. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol. Sci. 3:302-308.
172. Govan, J. R. W., J. E. Hughes, and P. Vandamme. Burkholderia cepacia: medical, taxonomic and ecolological issues. J. Med. Microbiol., in press.
173. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
174. Govan, J. R. W., and J. W. Nelson. 1993. Microbiology of cystic fibrosis lung infections: themes and issues. J. R. Soc. Med. 86(Suppl. 20):11-18.
175. Grabert, E., J. Wingender, and U. K. Winkler. An outer membrane protein characteristic of mucoid strains of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 56:83-87.
176. Grothues, D., U. Koopman, H. von der Hardt, and B. Tümmler. 1988. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol. 26:1973-1977.
177. Guggino, S. E. 1994. Gates of Janus: cystic fibrosis and diarrhea. Trends Microbiol. 2:91-94.
178. Haldenwang, W. 1995. The sigma factors of Bacillus subtilis. Microbiol. Rev. 59:1-30.
179. Hancock, R. E., L. M. Muthaira, L. Chan, R. P. Darveau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypeable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:170-177.
180. Hatano, K., J. B. Goldberg, and G. B. Pier. 1993. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. J. Bacteriol. 175:5117-5128.
181. Hatano, K., J. B. Goldberg, and G. B. Pier. 1995. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63:21-26.
182. Hearst, J. E., and K. E. Elliot. Identifying the killer in cystic fibrosis. 1995. Nat Med. 1:626-627.
183. Hebbar, K. P., A. G. Davey, J. Merrin, T. J. McLoughlin, and P. J. Dart. 1992. Pseudomonas cepacia, a potential suppressor of maize soil-borne diseases-seed inoculation and maize root colonization. Soil Biol. Biochem. 24:999-1007.
184. Heidt, A., H. Monteil, and C. Richard. 1983. O and H serotyping of Pseudomonas cepacia. J. Clin. Microbiol. 18:738-740.
185. Henriksen, S. D. 1948. Some unusual mucoid organisms. Acta Pathol. Microbiol. Scand. 25:485-492.
186. Henry, R. L., D. C. Dorman, J. M. Brown, and C. Mellis. 1982. Mucoid Pseudomonas aeruginosa in cystic fibrosis. Aust. Paediatr. J. 18:43-45.
187. E). Proc. Natl. Acad. Sci. USA 92:7941-7945.
188. E, is essential for bacterial growth at high temperature. J. Bacteriol. 177:2918-2922.
189. Hobson, R., I. Gould, and J. Govan. 1995. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis externa. Eur. J. Clin. Microbiol. Infect. Dis. 4:980.
190. Høiby, N. 1977. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol. Microbiol. Scand. Sect. C Suppl. 262:3-96.
191. Høiby, N. 1982. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr. Scand. Suppl 301:33-54.
192. Høiby, N., G. Döring, and P. O. Schiötz. 1986. The role of immune complexes in the pathogenesis of bacterial infections. Annu, Rev. Microbiol. 40:29-53.
193. Höiby, N., E. W. Flesenborg, B. Beck, B. Friis, S. V. Jacobsen, and L. Jacobsen. 1977. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand. J. Respir. Dis. 58:65-79.
194. Holloway, B. W. 1992. Pseudomonas in the late 20th century, p. 1-8. In E. Galli, S. Silver, and B. Witholt (ed.), Pseudomonas. Molecular biology and biotechnology. American Society for Microbiology. Washington, D.C.
195. Holmes, B. 1986. The identification of Pseudomonas cepacia and its occurrence in clinical material. J. Appl. Bacteriol. 61:299-314.
196. Honicky, R., D. Harden, J. Hsu, W. Howatt, L. Kurlandsky, D. Homnick, T. Stull, J. LiPuma, W. Spohn, K. McCoy, R. Wilmott, J. Kanga, J. Christenson, D. Crozier, J. Reisman, W. Wilson, E. Eccleston, K. Keeley, S. FitzSimmons, and R. Beall. 1993. Pseudomonas cepacia at summer camps for persons with cystic fibrosis. Morbid. Mortal. Weekly Rep. 42:456-459.
197. Huang, N. N., E. L. van Loon, and K. T. Sheng. 1961. The flora of the respiratory tract of patients with cystic fibrosis of the pancreas. J. Pediatr. 59:512-521.
198. Huang, Y., B. J. Deverall, and S. C. Morris. 1993. Effect of Pseudomonas cepacia on postharvest biocontrol of infection by Penicillium digilatum and on wound responses of citrus fruit. Aust. J. Plant Pathol. 22:84-93.
199. Hughes, K. T., K. L. Gillen, M. J. Semon, and J. E. Karlinsey. 1993. Sensing structural intermediates in bacterial flagellar assembly by export of a negative regulator. Science 262:1277-1280.
200. Iacocca, V. F., M. S. Sibinga, and G. J. Barbero. 1963. Respiratory tract bacteriology in cystic fibrosis. Am. J. Dis. Child. 106:316-324.
201. Imundo, L., J. Barasch, A. Prince, and Q. Al-Awqati. 1995. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. USA 92:3019-3023.
202. Ishikuri, S., H. Uchino, and K. Kanzawa. 1992. Isolation of Pseudomonas cepacia D-202: an available biocontrol agent to the storage rot of sugar beet. Ann. Phytopathol. Soc. Jpn. 58:456-460.
203. Ishimoto, K. S., and S. Lory. 1989. Formation of pilin in Pseudomonas aeruginosa requires the alternative σ factor (RpoN) of RNA polymerase. Proc. Natl. Acad. Sci. USA 86:1954-1957.
204. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
205. Janisiewiez, W. J., and J. Roitman. 1988. Biological control of blue and gray mold on apple and pear with Pseudomonas cepacia. Phytopathology 78: 1697-1700.
206. Jarvis, W. R., D. Olson, O. Tablan, and W. J. Martone. 1987. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur. J. Epidemiol. 3:233-236.
207. Jensen, E. T., A. Kharazmi, K. Lam, J. W. Costerton, and N. Høiby. 1990. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect. Immun. 58:2383-2385.
208. Jin, S., K. Ishimoto, and S. Lory. 1994. Nucleotide sequence of the rpoN gene and characterization of two downstream open reading frames in Pseudomonas aeruginosu. J. Bacteriol. 176:1316-1322.
209. Johansen, H. K., S. J. Cryz, and N. Hoiby. 1994. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A. APMIS 102:545-553.
210. Johansen, H. K., F. Espersen, S. J. Cryz, Jr., H. P. Hougen, A. Fomsgaard, J. Rygaard, and N. Hoiby. 1994. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect. Immun. 62:3146-3155.
211. Johansen, H. K., and N. Hoiby. 1992. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47:109-111.
212. Johnson, K., I. Charles, G. Dougan, D. Pickard, P. O'Gaora, G. Costa, T. Ali, I. Miller, and C. Hormaeche. 1991. The role of stress-response protein in Salmonella typhimurium virulence. Mol. Microbiol. 5:401-407.
213. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
214. Joris, B., M. Galleni, J. M. Frère, and R. Labia. 1994. Analysis of the penA gene of Pseudomonas cepacia 249. Antimicrob. Agents Chemother. 38:407-408. (Letter.)
215. Kanthakumar, K., D. R. Cundell, G. W. Taylor, P. J. Willis, M. Johnson, P. J. Cole, and R. Wilson. 1994. The effect of salmetrol and dibutyryl cyclic AMP on the cyclic AMP-mediated slowing of human ciliary beat in vitro produced by the Pseudomonas aeruginosa toxins 1-hydroxyphenazine and rhamnolipid. Br. J. Pharmacol. 112:493-498.
216. Kanthakumar, K., G. Taylor, K. W. T. Tsang, D. R. Cundell, A. Rutman, P. K. Jeffrey, P. J. Cole, and R. Wilson. 1993. Mechanism of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect. Immun. 61:2848-2853.
217. Kapur, V., T. S. Whittam, and J. M. Musser. 1994. Is Mycobacterium tuberculosis 15,000 years old? J. Infect. Dis. 170:1348-1349.
218. Karpati, F., A.-S. Malmborg, H. Alfredsson, L. Hjelte, and B. Strandvik. 1994. Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population. Infection 22:258-263.
219. Kato, J., and A. M. Chakrabarty. 1991. Purification of the regulatory protein AlgR1 and its binding in the far upstream region of the algD promoter in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 88:1760-1764.
220. Kato, J., L. Chu, K. Kitano, J. D. DeVault, K. Kimbara, A. M. Chakrabarty, and T. K. Misra. 1989. Nucleotide sequence of the regulatory region controlling alginate synthesis in Pseudomonas aeruginosa: characterization of the algR2 gene. Gene 84:31-38.
221. Kato, J., T. K. Misra, and A. M. Chakrabarty. 1990. AlgR3, a protein resembling eukaryotic histone H1, regulates alginate synthesis in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 87:2887-2891.
222. Kelly, N. M., J. L. Kluftinger, B. L. Paslowske, W. Paranchych, and R. E. W. Hancock. 1989. Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages. Infect. Immun. 57:3841-3845.
223. Kerem, B.-S., J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L.-C. Tsui. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
224. Kerem, E., M. Corey, R. Gold, and H. Levison. 1990. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 116:714-719.
225. Kerr, J. 1994. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J. Infect. 28:305-310.
226. Kersulyte, D., M. J. Struelens, A. Deplano, and D. E. Berg. 1995. Comparison of arbitrary primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J. Clin. Microbiol. 33:2216-2219.
227. Khan, T. Z., J. S. Wagner, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
228. Kharizmi, A., P. O. Schiotz, T. Jensen, L. Baek, and N. Hoiby. 1987. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur. J. Clin. Invest. 17:256-261.
229. Kidambi, S. P., G. W. Sundin, D. A. Palmer, A. M. Chakrabarty, and C. L. Bender, 1995. Copper as a signal for alginate synthesis in Pseudomonas syringae pv. syringae. Appl. Environ. Microbiol. 61:2172-2179.
230. Kilbourn, J. P. 1978. Bacterial content and ionic composition of sputum in cystic fibrosis. Lancet i:334.
231. King, E. B., and J. L. Parke. 1993. Biocontrol of Aphanomyces root rot and Pythium damping-off by Pseudomonas cepacia AMMD on four pea cultivars. Plant Dis. 77:1185-1188.
232. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkhotderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
233. Kluftinger, J. L., N. M. Kelly, H. Jot, and R. E. W. Hancock. 1989. Fibroneclin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages. Infect. Immun. 57:2782-2785.
234. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069.
235. Komiyami, K., B. F. Habbick, and S. K. Tumber. 1987. Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Infect. Immun. 55:2364-2369.
236. Konyecsni, W. M., and V. Deretic. 1990. DNA sequence and expression analysis of algP and algQ, components of the multigene system transcriptionally regulating mucoidy in Pseudomonas aeruginosa: algP contains multliple direct repeats. J. Bacteriol. 172:2511-2520.
237. Kostman, J. R., T. D. Edlind, J. J. LiPuma, and T. L. Stull. 1992. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J. Clin. Microbiol. 30:2084-2087.
238. Krieg, D. P., J. A. Bass, and S. J. Mattingly. 1986. Aeration selects for mucoid phenotype of Pseudomonas aeruginosa. J. Clin. Microbiol. 24:986-990.
239. Krieg, D. P., J. A. Bass, and S. J. Mattingly. 1988. Phosphorylcholine stimulates capsule formation of phosphate-limited mucoid Pseudomonas aeruginosa. Infect. Immun. 56:864-873.
240. Krieg, D. P., R. J. Helmk, V. F. German, and J. A. Mangos. 1988. Resistance of mucoid Pseudomonas aeruiginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Infect. Immun. 56:3173-3179.
241. Krivan, H. C., V. Ginsburg, and D. D. Roberts. 1988. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosyl-ceramide (asialo GM2). Arch. Biochem. Biophys. 260:493-496.
242. Krivan, H. C., D. D. Roberts, and V. Ginsburg. 1988. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. USA 85:6157-6161.
243. Kronborg, G., M. B. Hansen, M. Svenson, A. Fomsgaard, N. Hoiby, and K, Benutzen. 1993. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr. Pulmonol. 15:292-297.
244. Kubesch, P., T. Dörk, U. Wulbrand, N. Kälin, T. Neumann, B. Wulf, H. Geerlings, H. Weissbrodt, H. von der Hardt, and B. Tümmler. 1993. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet 341:189-193.
245. Kuehn, M., K. Lent, J. Haas, J. Hagenzieker, M. Cervin, and A. L. Smith. 1992. Fimbriation of Pseudomonas cepacia. Infect. Immun. 60:2002-2007.
246. Kumon, H., K. Tomochika, T. Mutunaga, M. Ogawa, and H. Ohmori. 1994. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol. Immunol. 38:615-619.
247. Lacy, D. E., A. W. Smith, D. E. Stableforth, G. Smith, P. H. Weller, and M. R. W. Brown. 1995. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 10:253-262.
248. Lacy, D. E., D. A. Spencer, A. Goldstein, P. H. Weller, and P. Darbyshire. 1993. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J. Infect. 27:301-304.
249. Lam, J., R. Chan, K. Lam, and J. W. Costerton. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
250. Larsen, G. Y., T. L. Stull, and J. L. Burns. 1993. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J. Clin Microbiol. 31:788-792.
251. Learn, D. B., E. P. Brestel, and S. Seetharama. 1987. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 55:1813-1818.
252. Lessie, T. G., and P. V. Phibbs. 1984. Alternative pathways of carbohydrate utilization in pseudomonads. Annu. Rev. Microbiol. 38:359-387.
253. Lessie, T. G., M. S. Wood, A. Byrne, and A. Ferrante. 1990. Transposable gene-activating elements in Pseudomonas cepacia, p. 271-291. In S. Silver, A. M. Chakrabarty, B. Iglewski, and S. Kaplan (ed.), Pseudomonas: bio-transformations, pathogenesis, and evolving biotechnology. American Society for Microbiology, Washington, D.C.
254. Lewin, C., C. Doherty, and J. R. W. Govan. 1993. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, cotrimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob. Agents Chemother. 37:123-125.
255. Li, X.-Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-
256. Li, X.-Z., H. Nikaido, and K. Poole, 1995. The role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:1742-1752.
257. Lightfoot, J., and J. S. Lam. 1993. Chromosomal mapping, expression and synthesis of lipopolysaccharide in Pseudomonas aeruginosa: a role for guanine diphospho (GDP)-D-mannose. Mol. Microbiol. 8:771-782.
258. Lindem, S. E. 1992. Environmental release of pseudomonads: potential benefits and risks, p. 399-407. In E. Galli, S. Silver, and B. Witholt (ed.), Pseudomonas. Molecular biology and biotechnology. American Society for Microbiology, Washington, D.C.
259. Linker, A., and R. S. Jones. 1964. A polysaccharide resembling alginic acid from a Pseudomonas micro-organism. Nature (London) 204:187-188.
260. Linker, A., and R. S. Jones. 1966. A new polysaccharide resembling alginic acid isolated from pseudomonads. J. Biol. Chem. 241:3845-3851.
261. Lipinska, B., O. Fayet, L. Baird, and C. Georgopoulos. 1989. Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures. J. Bacteriol. 171:1574-1584.
262. 32-independent mechanisms of heat-inducible transcription. Nucleic Acids Res. 16:10053-10067.
263. Lipinska, B., M. Zylcicz, and C. Georgopoulos. 1990. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J. Bacteriol. 172:1791-1797.
264. LiPuma, J. J., S. E. Dasen, D. W. Nielson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
265. LiPuma, J. J., M. C. Fisher, S. E. Dasen, J. E. Mortensen, and T. L. Stull. 1991. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J. Infect. Dis. 164:133-136.
266. LiPuma, J. J., K. A. Marks-Austin, D. S. Holsclaw, G. B. Winnie, P. H. Gilligan, and T. L. Stull. 1994. Inapparent transmission of Pseudomonas (Burkhohleria) cepacia among patients with cystic fibrosis. Pediatr. Infect. Dis. J. 13:716-719.
267. LiPuma, J. J., and T. L. Stull. 1995. Burkholderia cepacia in cystic fibrosis. N. Engl. J. Med. 332:820. (Letter.)
268. List 45. 1993. Validation of the publication of new names and new combinations previously effectively published outside the IJSB. Int. J. Syst. Bacteriol. 43:398-399.
269. Littlewood, J. M., M. G. Miller, A. G. Ghoneim, C. H. Ramsden. 1985. Nebulised colomycin for early pseudomonas colonization in cystic fibrosis. Lancet i:865.
270. Lonetto, M. A., K. L. Brown, K. E. Rudd, and M. J. Buttner. 1994. Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase σ factors involved in the regulation of extracytoplasmic functions. Proc. Natl. Acad. Sci. USA 86:7573-7577.
271. 70 family: sequence conservation and evolutionary relationship. J. Bacteriol. 174:3843-3849.
272. Lonon, M. K., D. E. Woods, and D. C. Straus. 1988. Production of lipase by clinical isolates of Pseudomonas cepacia. J. Clin. Microbiol. 26:979-984.
273. Lynn, A. R., and J. R. Sokatch. 1984. Incorporation of isotope from specifically labeled glucose into alginates of Pseudomonas aeruginosa and Azotobacter vinelandii. J. Bacteriol. 158:1161-1162.
274. Ma, S., and D. E. Ohman. 1996. Pseudomonas aeruginosa algK encodes a histidine protein kinase that phosphorylates AlgB, abstr. B-123, p. 176. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
275. MacGeorge, J., V. Korolik, A. F. Morgan, V. Asche, and B. W. Holloway. 1986. Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO. J. Med. Microbiol. 21:331-336.
276. Maharaj, R., T. B. May, S.-K. Wang, and A. M. Chakrabarty. 1993. Sequence of the alg8 and alg44 genes involved in the synthesis of alginate by Pseudomonas aeruginosa. Gene 136:267-269.
277. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
278. Mai, G. T., J. G. McCormack, W. K. Seow, G. B. Pier, L. A. Jackson, and Y. H. Thong. 1993. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase-specific monoclonal antibodies and antibiotics. Infect. Immun. 61:4338-4343.
279. Mai, G. T., W. K. Seow, G. B. Pier, J. G. McCormack, and Y. H. Thong. 1993. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physiochemical, alginase, and specific monoclonal antibody treatments. Infect. Immun. 61:559-564.
280. Marcus, H., and N. R. Baker. 1985. Quantitation of adherence of mucoid and nonmucoid Pseudomonas aeruginosa to hamster tracheal epithelium. Infect. Immun. 47:723-729.
281. Marrie, T. J., G. K. Harding, A. R. Ronald, J. Dikkema, J. Lam, S. Hoban, and J. W. Costerton. 1979. Influence of mucoidy on antibody coating of Pseudomonas aeruginosa. J. Infect. Dis. 139:357-361.
282. Martin, C., M. A. Ichou, P. Massicot, A. Goudeau, and R. Quentin. 1995. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J. Clin. Microbiol. 33:1461-1466.
283. Martin, D. W., B. W. Holloway, and V. Deretic. 1993. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol. 175: 1153-1164.
284. Martin, D. W., M. J. Schurr, M. H. Mudd, and V. Deretic. 1993. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol. Microbiol. 9:495-506.
285. Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. W. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90:8377-8381.
286. Martin, D. W., M. J. Schurr, H. Yu, and V. Deretic. 1994. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to stress response. J. Bacteriol. 176:6688-6696.
287. Martinez-Salazar, J. M., S. Moreno, R. Najera, J. C. Boucher, G. Espin, G. Soberon-Chavez, and V. Deretic. 1996. Characterization of the genes encoding the putative sigma factor AlgU, and its regulators MucA, MucB. MucC, and MucD in Azotobacter vinelandii and evaluation of their role in alginate biosynthesis. J. Bacteriol. 178:1800-1808.
288. Martinsen, A. G. Skjak-Braek, and O. Smidsrod. 1989. Alginate as immobilization material. I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol. Bioeng. 33:79-89.
289. Martone, W. J., O. C. Tablan, and W. R. Jarvis. 1987. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur. J. Epidemiol. 3:222-232.
290. May, T. B., and A. M. Chakrabarty. 1994. Pseudomonas aeruginosa: genes and enzymes of alginate synthesis. Trends Microbiol. 2:151-157.
291. May, T. B., D. Shinabarger, R. Maharaj, J. Kato, L. Chu, J. D. DeVault, S. Roychoudhury, N. Zielinski, A. Berry, R. K. Rothmel, T. K. Mistra, and A. M. Chakrabarty. 1991. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin. Microbiol. Rev. 4:191-206.
292. McAvoy, M. J., V. Newton, A. Paull, J. Morgan, P. Gacesa, and N. J. Russell. 1989. Isolation of mucoid strains of Pseudomonas aemginosa from non-cystic fibrosis patients and characterisation of the structure of their secreted alginate. J. Med. Microbiol. 28:183-189.
293. McEachran, D. W., and R. T. Irvin. 1985. Adhesion of Pseudomonas aeruginosa to human buccal epithelial cells: evidence for two classes of receptors. Can. J. Microbiol. 31:563-569.
294. McGowan, S. J., H. C. Gorham, and D. A. Hodgson. 1993. Light-induced carotenogenesis in Myxococcus xanthus: DNA sequence analysis of the carR region. Mol. Microbiol. 10:713-725.
295. McKevitt, A. I., S. Bajaksouzian, J. D. Klinger, and D. E. Woods. 1989. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect. Immun. 57:771-778.
296. McKevitt, A. L, and D. E. Woods. 1984. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J. Clin. Microbiol. 19:291-293.
297. McLoughlin, T. J., J. P. Quinn, A. Bettermann, and R. Bookland. 1992. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl. Environ. Microbiol. 58:1760-63.
298. E, an Escherichia coli heat-inducible σ-factor, is modulated by expression of outer membrane proteins. Genes Dev. 7:2618-2628.
299. n with DNA. Proposed coiled-coil structure of AlgR3 and AlgP from Pseudomonas aeruginosa. Protein Eng. 8:63-70.
300. Meshulam, T., N. Obedeanu, D. Merbach, and J. D. Sobel. 1984. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Clin. Immunol. Immunopathol. 32:151-165.
301. Meyer, J.-M., D. Hohnadel, and F. Halle. 1989. Cepabactin from Pseudomonas cepacia, a new type of siderophore. J. Gen. Microbiol. 135:1479-1487.
302. Millar-Jones, L., A. Paull, Z. Saunders, and M. C. Goodchild. 1992. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 340:491.
303. F, the first compartment-specific transcription factor of B. subtilis, is regulated by an anti-σ factor that is also a protein kinase. Cell 74:735-742.
304. Mohr, C. D., and V. Deretic. 1990. Gene-scrambling mutagenesis: generation of insertional mutations in the alginate regulatory region of Pseudomonas aeruginosa. J. Bacteriol. 172:6252-6260.
305. Mohr, C. D., and V. Deretic. 1992. In vitro interactions of the histone-like protein IHF with the algD promoter, a critical site for control of mucoidy in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 189:837-844.
306. Mohr, C. D., N. S. Hibler, and V. Deretic. 1991. AlgR, a response regulator controlling mucoidy in Pseudomonas aeruginosa, binds to the FUS sites of the algD promoter located unusually far upstream from the mRNA start site. J. Bacteriol. 173:5136-5143.
307. Mohr, C. D., J. H. J. Leveau, D. P. Krieg, N. S. Hibler, and V. Deretic. 1992. AlgR-binding sites within the algD promoter make up a set of inverted repeats separated by a large intervening segment of DNA. J. Bacteriol. 174:6624-6633.
308. Mohr, C. D., D. W. Martin, W. M. Konyecsni, J. R. W. Govan, S. Lory, and V. Deretic. 1990. Role of the far-upstream sites of the algD promoter and the algR and rpoN genes in environmental modulation of mucoidy in Pseudomonas aeruginosa. J. Bacteriol. 172:6576-6580.
309. Mohr, C. D., S. K. Sonsteby, and V. Deretic. 1994. The Pseudomonas aeruginosa homologs of hemC and hemD are linked to the gene encoding the regulator of mucoidy AlgR. Mol. Gen. Genet. 242:177-184.
310. Monday, S. R., and N. L. Schiller. 1996. Alginate synthesis in Pseudomonas aeruginosa: the role of AlgL (alginate lyase) and AlgX. J. Bacteriol. 178: 625-632.
311. Mork, T., and R. E. W. Hancock. 1993. Mechanisms of nonopsoic phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 61:3287-3293.
312. Mortensen, J., A. Hansen, M. Falk, I. K. Nielsen, and S. Groth. 1993. Reduced effect of inhaled beta-2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 103:805-811.
313. Mortensen, J. E., M. C. Fisher, and J. J. LiPuma. 1995. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect. Control Hosp. Epidemiol. 16:30-32.
314. Mulelini, G. J., M. Grout, D. J. Evans, and G. B. Pier. 1995. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by antibodies produced during chronic lung infection in cystic fibrosis. J. Immunol. 155:2029-2038.
315. Nakamura, Y., S. Hyodo, E. Chonan, S. Shigeta, and E. Yabuuchi. 1986. Serological classification of Pseudomonas cepacia by somatic antigen. J. Clin. Microbiol. 24:152-154.
316. Nakazawa, T., Y. Yamada, and M. Ishibashi. 1987. Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J. Clin. Microbiol. 25:195-198.
317. 13C-n.m.r. spectroscopy to monitor alginate biosynthesis in mucoid Pseudomonas aeruginosa. Biochem. J. 267:579-584.
318. Nelson, J. W., S. L. Butler, P. H. Brown, A. P. Greening, and J. R. W. Govan. 1993. Serum IgG and sputum IgA antibody to core Iipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J. Med. Microbiol. 39:39-47.
319. Nelson, J. W., S. L. Butler, D. Krieg, and J. R. W. Govan. 1994. Virulence factors of Burkholderia cepacia. FEMS Immunol. Med. Microbiol. 8:89-98.
320. Nelson, J. W., C. J. Doherty, P. H. Brown, A. P. Greening, M. E. Kaufmann, and J. R. W. Govan. 1991. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 338:1525.
321. Nelson, J. W., M. W. Tredgett, J. K. Sheehan, D. J. Thornton, D. Notman, and J. R. W. Govan. 1990. Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect, Immun. 58:1489-1495.
322. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. L. Walmsley. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32:518-523.
323. Nickel, J. C., J. B. Wright, I. Ruseska, T. J. Marrie, C. Whitfield, and J. W. Costerton. 1985. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur. J. Clin. Microbiol. 4:213-218.
324. Norman, D., J. S. Elborn, S. M. Cordon, R. J. Rayner, M. S. Wiesman, E. J. Hiller, and D. J. Shale. 1991. Plasma tumor necrosis factor alpha in cystic fibrosis. Thorax 46:91-95.
325. Ohnishi, K., K. Kutsukake, H. Suzuki, and T. Ino. 1992. A novel transcriptional regulation mechanism in the flagellar regulon of Salmonella typhimurium: an anti-sigma factor inhibits the activity of the flagellum-specific sigma factor, F. Mol. Microbiol. 6:3149-3157.
326. Oliver, A. M., and D. M. Weir. 1983. Inhibition of bacterial binding to mouse macrophages by pseudomonas alginate. J. Clin. Lab. Immunol. 10: 221-224.
327. O'Neil, K. M., J. H. Herman, J. F. Modlin, E. R. Moxon, and J. A. Winkelstein. 1986. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J. Pediatr. 108:940-942.
328. Osman, S. F., W. F. Fett, and M. L. Fishman. 1986. Exopolysaccharides of the phytopathogen Pseudomonas syringae pv. glycinea. J. Bacteriol. 166:66-71.
329. Otterlei, M., K. Ostgaard, G. Skjak-Braek, O. Smidsrod, P. Soon-Shiong, and T. Espevik. 1991. Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 10:286-291.
330. Otterlei, M., A. Sundan, G. Skjak-Braek, L. Ryan, O. Smidsrod, and T. Espevik. 1993. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect. Immun. 61:1917-1925.
331. Ouchi, K., M. Abe, M. Karita, T. Oguri, J. Igari, and T. Nakazawa. 1995. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J. Clin. Microbiol. 33:2353-2357.
332. Page, W. J., and H. L. Sadof. 1975. Relationship between calcium and uronic acids in the encystment of Azotobacter vinelandii. J. Bacteriol. 122: 145-151.
333. Parkinson, J. S. 1993. Signal transduction schemes of bacteria. Cell 73:857-871.
334. Parkinson, J. S., and E. C. Kofoid. 1992. Communication modules in bacterial signaling proteins. Annu. Rev. Genet. 26:71-112.
335. Parr, T. R., R. A. Moore, L. V. Moore, and R. E. W. Hancock. 1987. Role of porins in intrinsic resistance of Pseudomonas cepacia. Antimicrob. Agents Chemother. 31:121-123.
336. Pedersen, S. S. 1992. Lung infection with alginate-producing, mucoid
337. Pedersen, S. S., F. Espersen, N. Hoiby, and T. Jensen. 1990. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J. Clin. Microbiol. 28:747-755.
338. Pedersen, S. S., F. Espersen, N. Hoiby, and G. H. Shand. 1989. Purification, characterization, and immunological cross-reactivity of alginates produced bv mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 27:691-699.
339. Pedersen, S. S., N. Hoiby, F. Espersen, and C. Koch. 1992. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47:6-13.
340. Pedersen, S. S., T. Jensen, T. Pressler, N. Hoiby, and K. Rosendal. 1986. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr. Scand. 75:840-845.
341. Pedersen, S. S., A. Kharizmi, F. Espersen, and N. Hoiby, 1990. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect. Immun. 58:3363-3368.
342. Pegues, D. A., L. A. Carson, O. C. Tablan, S. C. FitzSimmons, S. B. Roman, J. M. Miller, W. R. Jarvis, and the Summer Camp Study Group. 1994. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J. Pediatr. 124:694-702.
343. Pfeffer, K. D., T. P. Huecksteadt, and J. R. Hoidal. 1993. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am. J. Respir. Cell. Mol. Biol. 9:511-519.
344. Pier, G. B. 1991. Vaccine potential of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate), p. 136-142. In J. Y. Homma, H. Tanimoto, I. A. Holder, N. Høiby, and G. Döring (ed.) Pseudomonas aeruginosa in human diseases. S. Karger, Basel.
345. Pier, G. B., D. Desjardins, R. Aquilhar, M. Barnard, and D. P. Speert. 1986. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J. Clin. Microbiol. 24:189-196.
346. Pier, G. B., D. DesJardins, M. Grout, S. E. Bennett, G. Pekoe, S. A. Fuller, M. O. Thornton, W. S. Harkonen, and H. C. Miller. 1995. Human immune response to Pseudomonas aeruginosa exopolysaccharide (alginate) vaccine. Infect. Immun. 62:3972-3979.
347. Pier, G. B., and M. E. Elcock. 1984. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J. Immunol. 133:734-739.
348. Pier, G. B., M. Grout, and D. Desjardins. 1991. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins. J. Immunol. 147:1869-1876.
349. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
350. Pier, G. B., G. Meluleni, and E. Neuger. 1992. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect. Immun. 60:4768-4776.
351. Pier, G. B., J. M. Saunders, P. Ames, M. S. Edwards, H. Auerbach, J. Goldfarb, D. P. Speert, and S. Hurwitch. 1987. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients. N. Engl. J. Med. 317:793-798.
352. Pier, G. B., G. J. Small, and H. B. Warren. 1990. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science 249:537-540.
353. Pier, G. B., S. Takeda, M. Grout, and R. B. Markham. 1993. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. J. Clin. Invest. 91:1079-1087.
354. Piggot, N. H., I. W. Sutherland, and T. R. Jarman. 1981. Enzymes involved in the biosynthesis of alginate by Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 13:179-183.
355. Pindar, D. F., and C. Bucke. 1975. The biosynthesis of alginic acid by Azotobacler vinelandii. Biochem. J. 152:617-622.
356. Pitt, T. L., and J. R. W. Govan. 1993. Pseudomonas cepacia and cystic fibrosis. PHLS Microbiol. Dig. 10:69-72.
357. Pitt, T. L., M. E. Kaufmann, P. S. Patel, L. C. A. Benge, S. Gaskin, and D. M. Livermore. 1996. Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:203-210.
358. Poole, K., K. Krebs, C. McNally, and S. Nehsat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
359. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 108:830-834.
360. Prince, A. 1992. Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract. Microb. Pathog. 13:251-260.
361. Proenca, R., W. W. Nui, G. Cacalano, and A. Prince. 1993. The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal β-lactamases. Antimicrob. Agents Chemother. 37:667-674.
362. Pugashetti, B. K., H. M. Metzger, Jr., L. Vadas, and D. S. Feingold. 1982. Phenorypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains. J. Clin. Microbiol. 16:686-691.
363. Pugashetti, B. K., L. Vadas, H. S. Prihar, and D. S. Feingold. 1983. GDP-mannose dehydrogenase and biosynthesis of alginate-like polysaccharide in a mucoid strain of Pseudomonas aeruginosa. J. Bacteriol. 153:1107-1110.
364. Pujol, M., X. Corbella, J. Carratala, and F. Gudiol. 1992. Community acquired bacteraemic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin. Infect. Dis. 15:887-888.
365. 24) heat shock sigma factor of Escherichia coli. EMBO J. 14:1043-1055.
366. Ramphal, R., C. Guay, and G. B. Pier. 1987. Pseudomonas aeruginosa adhesins to tracheobronchial mucin. Infect. Immun. 55:600-603.
367. Ramphal, R., and G. B. Pier. 1985. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect. Immun. 47:1-4.
368. Ratnaningsih, E. S., S. Dharmsthiti, V. Krishnapillai, A. Morgan, M. Sinclair, and B. W. Holloway. 1990. A combined physical and genetic map of Pseudomonas aeruginosa PAO. J. Gen. Microbiol. 136:2351-2357.
369. Rehm, B. H., G. Boheim, J. Tommassen, and U. K. Winkler. 1994. Overexpression of algE in Escherichia coli: subcellular localization, purification, and ion channel properties. J. Bacteriol. 176:5639-5647.
370. Reynolds, H. Y., P. A. Di Sant'Agnese, and H. Zierdt. 1976. Mucoid Pseudomonas aeruginosa: a sign of cystic fibrosis in young adults with chronic pulmonary disease. JAMA 236:2190-2192.
371. Richman-Eisenstat, J. B. Y., P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important chernoattractant in sputum of patients with chronic inflammatory airway disease. Am. J. Physiol. 264: L413-L418.
372. Riordan, J. R., J. M. Rommens, B.-S. Kerem, N. Alon, R. Rozmahel, K. Grzelczak, J. Zielenski, J. Lok, S. Plasic, J.-L. Chou, M. L. Drumm, M. C. Ianuzzi, F. S. Collins, and L.-C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
373. Rodley, P. D., U. Römling, and B. Tümmler. 1995. A physical genome map of the Burkholderia (Pseudomonas) cepacia type strain. Mol. Microbiol. 17:57-67.
374. Römling, U., B. Fielder, J. Bosshammer, D. Grothues, J. Greipel, H. von der Hardt, and B. Tummler. 1994. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170:1616-1621.
375. Römling, U., J. Wingender, H. Müller, and B. Tümmler. 1994. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl. Environ. Microbiol. 60:1734-1738.
376. Rommens, J. M., M. C. Ianuzzi, B.-S. Kerem, M. L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J. L. Cole, D. Kennedy, N. Ilidaka, M. Zsiga, M. Buchwald, J. R. Riordan, L.-C. Tsui, and F. S. Collins. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1058-1065.
377. Roop, R. M., II, T. W. Fletcher, N. M. Sriranganathan, S. M. Boyle, and G. G. Schurig. 1994. Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect. Immun. 62:1000-1007.
378. Rosenstein, B. J., and D. E. Hall. 1980. Pneumonia and septicaemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med. J. 147:188-189.
379. E, in Escherichia coli. EMBO J. 14:1032-1042.
380. Roychoudhury, S., T. B. May, J. F. Gill, S. K. Singh, D. S. Feingold, and A. M. Chakrabarty. 1989. Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosa. J. Biol. Chem. 264:9380-9385.
381. Roychoudhury, S., K. Sakai, and A. M. Chakrabarty. 1992. AlgR2 is an ATP/GTP-dependent protein kinase involved in alginate synthesis by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 89:2659-2663.
382. Roychoudhury, S., K. Sakai, D. Schlictman, and A. M. Chakrabarty. 1992. Signal transduction in exopolysaccharide alginate synthesis: phosphorylation of the response regulator algR1 in Pseudomonas aeruginosa and Escherichia coli. Gene 112:45-51.
383. Roychoudhury, S., N. A. Zielinski, A. J. Ninfa, N. E. Allen, L. N. Jungheim, T. I. Nicas, and A. M. Chakrabarty. 1993. Inhibitors of two-component signal transduction systems: inhibition of alginate gene activation in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 90:965-969.
384. Russell, N. J., and P. Gacesa. 1988. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis. Mol. Aspects Med. 10:1-91.
385. Sadof, H. L. 1975. Encystment and germination in Azotobacter vinelandii. Bacteriol. Rev. 39:516-539.
386. Sage A., A. Linker, L. R. Evans, and T. G. Lessie. 1990. Hexose phosphate metabolism and exopnlysaccharide formation in Pseudomonas cepacia. Curr. Microbiol. 20:191-198.
387. Saiman, L., G. Cacalano, and A. Prince. 1990. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect. Immun. 58:2578-2584.
388. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1875-1880.
389. Saiman, L., J. Sadoff, and A. Prince. 1989. Cross-reactivity of Pseudomonas aeruginosa antipilin monoclonal antibodies with heterogeneous strains of P. aeruginosa and Pseudomonas cepacia. Infect. Immun. 57:2764-2770.
390. Sajjan, U. S., M. Corey, M. A. Karmali, and J. F. Forstner. 1992. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J. Clin. Invest. 89:648-656.
391. Sajjan, U. S., and J. F. Forstner. 1992. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect. Immun. 60:1434-1440.
392. Sajjan, U. S., L. Sun, R. Goldstein, and J. F. Forstner. 1995. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177:1030-1038.
393. Schiller, N. L., R. A. Hatch, and K. A. Joiner. 1989. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect. Immun. 57:1707-1713.
394. Schiller, N. L., S. R. Monday, C. M. Boyd, N. T. Keen, and D. E. Ohman. 1993. Characterization of the Pseudomonas aeruginosa alginate lyase gene (algL): cloning, sequencing, and expression in Escherichia coli. J. Bacteriol. 175:4780-4789.
395. Schlictman, D., A. Kavanaugh-Black, S. Shankar, and A. M. Chakrabarty. 1994. Energy metabolism and alginate biosynthesis in Pseudomonas aeruginosa: role of the tricarboxylic acid cycle. J. Bacteriol. 176:6023-6029.
396. Schlictman, D., M. Kubo, S. Shankar, and A. M. Chakrabarty. 1995. Regulation of nucleoside diphosphate kinase and secretable virulence factors in Pseudomonas aeruginosa: roles of algR2 and algH. J. Bacteriol. 177:2469-2474.
397. Schurr, M. J., D. W. Martin, M. H. Mudd, and V. Deretic. 1994. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J. Bacteriol. 176:3375-3382.
398. Schurr, M. J., D. W. Martin, M. H. Mudd, N. S. Hibler, J. C. Boucher, and V. Deretic. 1993. The algD promoter: regulation of alginate production by Pseudomonas aeruginosa in cystic fibrosis. Cell. Mol. Biol. Res. 39:371-376.
399. E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J. Bacteriol. 177:5670-5679.
400. E-like family of sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J. Bacteriol. 78:4997-5004.
401. Sehurr, M. J., H. Yu, J. M. Martinez-Salazar, N. S. Hibler, and V. Deretic. 1995. Biochemical characterization and posttranslational modification of AlgU. a regulator of stress response in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 216:874-880.
402. Schwarzmann S., and J. R. Boring. 1971. Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect. Immun. 3:762-767.
403. Schweizer, H. P., C. P., M. K. Bacic. 1995. Identification of Pseudomonas aeruginosa glpM, whose gene product is required for efficient alginate biosynthesis from various carbon sources. J. Bacteriol. 177:4801-4804.
404. Scordilis, G. E., H. Ree, and T. G. Lessie. 1987. Identification of transposable elements which activate gene expression in Pseudomonas cepacia. J. Bacteriol. 169:8-13.
405. Sengha, S. S., A. J. Anderson, A. J. Hacking, and E. A. Dawes. 1989. The production of alginate by Pseudomonas mendocina in batch and continuous culture. J. Gen. Microbiol. 135:759-804.
406. Shale, D. J. 1994. Cytokines in cystic fibrosis. p. 277-302. In J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis: current topics, vol. 2. John Wiley & Sons, Ltd., Chichester. England.
407. Shaw, D., I. R. Poxton, and J. R. W. Govan. 1995. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:99-106.
408. Shields, M. S., and M. J. Reagin. 1992. Selection of a Pseudomonas cepacia strain constitutive for the degradation of trichloroethylene. Appl. Environ. Microbiol. 58:3977-3983.
409. Shinabarger, D., A. Berry, T. May, R. Rothmel, A. Fialho, and A. M. Chakrabarty. 1991. Purification and characterization of phosphomannose isomerase-guanosine phospho-D-mannose pyrophosphorylase: a bifunctional enzyme in the alginate biosynthetic pathway of Pseudomonas aeruginosa. J. Biol. Chem. 266:2080-2088.
410. Shinabarger, D., T. B. May, A. Boyd, M. Ghosh, and A. M. Chakrabarty. 1993. Nucleotide sequence and expression of the Pseudomonas aeruginosa algF gene controlling acetylation of alginate. Mol. Microbiol. 9:1027-1035.
411. Simpson, D. A., R. Ramphal, and S. Lory. 1992. Genetic analysis of Pseudomonas aeruginosa adherence: distinct genetic loci control attachment of epithelial cells to mucins. Infect. Immun. 60:3771-3779.
412. Simpson, I. N., J. Finlay, D. J. Winstanley, N. Dewhurst, J. Nelson, S. Butler, and J. R. W. Govan. 1994. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J. Antimicrob. Chemother 34:353-361.
413. Simpson, I. N., R. Hunter, J. R. W. Govan, and J. W. Nelson. 1993. Do all Pseudomonas cepacia produce carbapenemases? J. Antimicrob. Chemother. 32:339-340.
414. Simpson, J. A., S. E. Smith, and R. T. Dean. 1988. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J. Gen. Microbiol. 134:29-36.
415. Simpson, J. A., S. E. Smith, and R. T. Dean. 1989. Scavenging by alginate of free radicals released by macrophages. Free Radical Biol. Med. 6:347-353.
416. Simpson, J. A., S. E. Smith, and R. T. Dean. 1993. Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Biochem. Mol. Biol. Int. 30:1021-1034.
417. Smith, D. L., E. G. Smith, L. B. Gumery, and D. E. Stableforth. 1992. Pseudomonas cepacia infection in cystic fibrosis. Lancet 339:252.
418. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
419. Smith, S. N., D. M. Steel, P. G. Middleton, F. M. Munkonge, D. M. Geddes, N. J. Caplen, D. J. Porteous, J. R. Dorin, and E. W. Alton. 1995. Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am. J. Physiol. 268:C297-C307.
420. Snouwaert, J. N., K. K. Brigman, A. M. Latour, N. N. Malouf, R. C. Boucher, O. Smithies, and B. Koller. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257:1083-1088.
421. Sokol, P. A. 1986. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J. Clin. Microbiol. 23:560-562.
422. Sokol, P. A., C. J. Lewis, and J. J. Dennis. 1992. Isolation of a novel siderophore from Pseudomonas cepacia. J. Med. Microbiol. 36:184-189.
423. Sokol, P. A., M.-Z. Luan, D. G. Storey, and P. Thirukkumaran. 1994. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J. Bacteriol. 176:553-562.
424. Sokol, P. A., and D. E. Woods. 1988. Effect of pyochelin on Pseudomonas cepacia respiratory infection. Microb. Pathog. 5:197-205.
425. Sonnenschein, C. 1927. Die Mucosus-form des Pyocyaneus-Bakteriums, Bacterium pyocyaneum mucosum. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. I Orig. 104:365-373.
426. Soon-Shiong, P., E. Feldman, R. Nelson, R. Heintz, Q. Yao, Z. Yao, T. Zheng, N. Merideth, G. Skjak-Braek, and T. Espvik. 1993. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. USA 90:5843-5847.
427. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-236. In A. L. Balten and R. P. Smith (ed.), Pseudomonas aeruginosa infections and treatment. Marcel Dekker, Inc., New York.
428. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of non-oxidative killine by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
429. Speert, D. P., M. E. Campbell, A. Davidson, F. George, and L. T. Wong. 1993. Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis. J. Infect. Dis. 167:226-229.
430. Speert, D. P., J. E. Dimmick, G. B. Pier, J. M. Saunders, R. E. W. Hancock, and N. Kelly. 1987. An immunohistological evaluation of Pseudomonas aerugitiosa pulmonary infection in two patients with cystic fibrosis. J. Clin. Microbiol. 22:743-747.
431. Speert, D. P., S. W. Farmer, M. E. Campbell, J. M. Musser, R. K. Selander, and S. Kuo. 1990. Conversion of Pseudomonas aeruginosa to the mucoid phenotype characteristic of strains from patients with cystic fibrosis. J. Clin. Microbiol. 28:188-194.
432. Speert, D. P., and S. Gordon. 1992. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose. J. Clin. Invest. 90:1085-1092.
433. Speert, D. P., B. A. Loch, D. A. Cabral, and I. E. Salit. 1986. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity. Infect. Immun. 53:207-212.
434. Stableforth, D. E., and D. L. Smith. 1994. Pseudomonas cepacia in cystic fibrosis. 1994. Thorax 49:629-630.
435. Staugas, R. E., D. P. Harvey, A. Ferrante, M. Nandoskar, and A. C. Allison. 1992. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma Interferon, and IL-1 production in human leukocytes. Infect. Immun. 60:3162-3168.
436. Steinbach, S., L. Sun, R.-Z. Jiang, P. Flume, P. Gilligan, T. M. Egan, and R. Goldstein. 1994. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N. Engl. J. Med. 331:981-987.
437. Stiver, H. G., K. Zachidniak, and D. P. Speert. 1988. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. Clin. Invest. Med. 11:247-252.
438. Stock, J. B., A. J. Ninfa, and A. M. Stock. 1989. Protein phosphorylation and the regulation of adaptive responses in bacteria. Microhiol. Rev. 53:450-490.
439. Stokke, B. T., O. Smidsrod, P. Bruheim, and G. Skjak-Braek. 1991. Distribution of uronate residues in alginate chains in relation to alginate gelling properties. Macromolecules 24:4637-4645.
440. Stover, B. G., D. R. Drake, and T. C. Montie. 1983. Virulence of different Pseudomonas species in a burned-mouse model: tissue colonization by Pseudomonas cepacia. Infect. Immun. 41:1099-1104.
441. Strauch, K., and J. Beckwith. 1988. An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. Proc. Natl. Acad. Sci. USA 85:1576-1580.
442. Straus, D. C., M. K. Lonon, and J. C. Hutson. 1992. Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase. J. Med. Microbiol. 37:335-340.
443. Straus, D. C., M. K. Lonon, D. E. Woods, and C. W. Garner. 1989. Production of an extracellular toxic complex by various strains of Pseudomonas cepacia. 3. Med. Microbiol. 30:17-22.
444. Stull, T. L., J. J. LiPuma, and T. D. Edlind. 1988. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J. Infect. Dis. 157:280-286.
445. Stutman, H. R., and M. I. Marks. 1987. Pulmonary infections in children with cystic fibrosis. Semin. Respir. Med. 2:166-176.
446. Su, C.-J., A. da Cunha, C. M. Wernette, R. N. Reusch, and H. L. Sadof. 1987. Protein synthesis during encystment of Azotobacter vinelandii. J. Bacteriol. 169:4451-4456.
447. + Pseudomonas (Burkhoideria) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1:661-666.
448. Suter, S., U. B. Schaad, P. Roux-Lombard, E. Girardin, G. Grau, and J.-M. Dayer. 1989. Relation between tumor necrosis factor-alpha and granulocyte elastase-α-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am. Rev. Respir. Dis. 140:1640-1644.
449. Sutherland, I. W. 1991. Alginates, p. 307-331. In D. Byrom (ed.), Biomaterials. Macmillan, New York.
450. Tablan, O. C., L. A. Carson, L. B. Cusick, L. A. Bland, W. J. Martone, and W. R. Jarvis. 1987. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J. Clin. Microbiol. 25:485-487.
451. Tablan, O. C., T. L. Chorba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Carson, W. J. Martone, J. M. Jason, and W. R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.
452. Takigawa, K., J. Fujita, K. Negayama, Y. Yamagishi, Y. Yamaji, K. Ouchi, K. Yamada, M. Abe, T. Nakazawa, K. Kawanishi, and J. Takahara. 1993. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebuliser devices. J. Jpn. Assoc. Infect. Dis. 67:1115-1124.
453. Taplin, D., D. C. J. Bassett, and P. M. Mertz. 1971. Foot lesions associated with Pseudomonas cepacia. Lancet ii:568-571.
454. Tatnell, P. J., N. J. Russell, and P. Gacesa. 1993. A metabolic study of the activity of GDP-mannose dehydrogenase and concentrations of activated intermediates of alginate biosynthesis in Pseudomonas aeruginosa. J. Gen. B Microbiol. 139:119-127.
455. Tatnell, P. J., N. J. Russell, and P. Gacesa. 1994. Chemical analysis of alginates from mucoid strains of Pseudomonas aeruginosa. Biochem. Soc. Trans. 22:310S.
456. Tatum, F. M., N. F. Cheville, and D. Morfitt. 1994. Cloning, characterization and construction htrA and htr-like mutants of Brucella abortus and their survival in BALB/c mice. Microb. Pathog. 17:23-36.
457. Terry, J. M., S. E. Pina, and S. J. Mattingly. 1991. Environmental conditions which influence mucoid conversion in Pseudomonas aeruginosa PAO1. Infect. Immun. 59:471-477.
458. The International Pseudomonas aeruginosa Typing Study Group. 1994. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J. Infect. Dis. 169:134-142.
459. Thomassen, M. J., C. A. Demko, B. Boxerbaum, R. C. Stern, and P. J. Kuchenbrod. 1979. Multiple isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patienls with cystic fibrosis. J. Infect. Dis. 140:873-880.
460. Thomassen, M. J., C. A. Demko, C. F. Doershuk, R. C. Stern, and J. D. Klinger. 1986. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:669-671.
461. Thomassen, M. J., C. A. Demko, J. D. Klinger, and R. C. Stern. 1985. Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist. Am. Rev. Respir. Dis. 131:791-796.
462. Tocaj, A., A. Hof, P. Hagander, and O. Holst. 1993. Fed-batch cultivation of Pseudomonas cepacia with on-line control of the toxic substrate salicylate. Appl. Microbiol. Biotechnol. 38:463-466.
463. Totten, P. A., J. C. Lara, and S. Lory. 1990. The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene. J. Bacteriol. 172:389-396.
464. Toussaint, B., I. Delic-Attree, and P. M. Vignais. 1993. Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter. Biochem. Biophys. Res. Commun. 196:416-421.
465. Tredgett, M. W., C. Doherty, and J. R. W. Govan. 1990. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways disease. J. Med. Microbiol. 32:169-172.
466. Valerius, N. H., C. Koch, and N. Høiby. 1991. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338:725-726.
467. Vandamme, P. 1995. Emerging new "Pseudomonas" species in cystic fibrosis. In 20th European Cystic Fibrosis Conference.
468. Varmus, M. E. 1995. Marshall E Varmus orders up a review of the science of gene therapy. Science 267:1588.
469. Vasil, M. L., C. Chamberlain, and C. C. R. Grant. 1986. Molecular studies of Pseudomonas exotoxin A gene. Infect. Immun. 52:538-548.
470. Vasil, M. L., D. P. Krieg, J. S. Kuhns, J. W. Ogle, V. D. Shortridge, R. M. Ostroff, and A. I. Vasil. 1990. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect. Immun. 58:4020-4029.
471. Venturi, V., M. Ottevanger, V. Korse, B. Brouwer, J. Leong, and P. Weisbeek. 1995. Alginate regulatory and biosynthetic gene homologs in Pseudomonas putida WCS358: correlation with the siderophore regulatory gene pfrA. Gene 155:83-88.
472. Venturi, V., C. Ottevanger, J. Leong, and P. Weisbeck. 1993. Identification and characterization of a siderophore regulatory gene (phrA) of Pseudomonas putida WCS358: homology to the alginate regulatory gene algQ of Pseudomonas aeruginosa. Mol. Microbiol. 10:63-73.
473. Venturi, V., P. Weisbeck, and M. Koster. 1995. Gene regulation in Pseudomonas: not only the Fur represser. Mol. Microbiol. 17:603-610.
474. Vishwanath, S., R. Ramphal, C. M. Guay, D. DesJardins, and G. B. Pier. 1988. Respiratory-mucoid inhibition of the opsonophagocytic killing of Pseudomonas aeruginosa. Infect. Immun. 56:2218-2222.
475. Wainwright, B. 1991. The molecular pathology of cystic fibrosis. Curr. Biol. 1:80-82.
476. Walters, S., and E. G. Smith. 1993. Pseudomonas cepacia in cystic fibrosis: transmissibility and implications. Lancet 342:3-4.
477. Wang, Q., and J. M. Kaguni. 1989. A novel sigma factor is involved in expression of the rpoH gene of Escherichia coli. J. Bacteriol. 171:4248-4253.
478. Wang, S. K., I. Sa'-Correia, A. Darzins, and A. M. Chakrabarty. 1987. Characterization of the Pseudomonas aeruginosa alginate (alg) gene region II. J. Gen. Microbiol. 133:2303-2314.
479. Warner, J. O. 1992. Immunology of cystic fibrosis. Br. Med. Bull. 48:893-911.
480. Welsh, M. J. 1993. Cystic fibrosis gene therapy using an adenovirus: in vivo safety and efficacy in the nasal epithelium. Fed. Regist. 58:21737.
481. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis, p. 3799-3876. In C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (ed.), The metabotic and molecular basis of inherited disease, vol. III. McGraw-Hill Inc., New York.
482. Wheeler, W. B., M. Williams, W. J. Matthews, Jr., and H. R. Colten. 1984. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study, J. Pediatr. 104:695-699.
483. Widdicombe, J. H., S. S. Miller, and W. E. Finkbeiner. 1994. Altered regulation of airway fluid content in cystic fibrosis, p. 109-129. In J. A. Dodge. D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis: current topics, vol. 2. John Wiley & Sons, Ltd., Chichester, England.
484. Wilson, R., D. Roberts, and P. Cole. 1985. Effect of bacterial products on human ciliary function in vitro. Thorax 40:125-131.
485. Wise, M. G., L. J. Shimkets, and J. V. McArthur. 1995. Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl. Environ. Microbiol. 61:1791-1798.
486. Woodruf, W., D. J. Hassett, and D. E. Ohman. 1992. Sequence analysis of Pseudomonas aeruginosa DNA containing the alginate gene algT revealed the adjacent gene nadB encoding aspartate oxidase, abstr. D-45. In Abstracts of the 92nd General Meeting of the American Society for Microbiology 1992. American Society for Microbiology, Washington, D.C.
487. Woods, D. E., J. A. Bass, W. G. Johansson, Jr., and D. C. Straus. 1980. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect. Immun. 30:694-699.
488. Woods, D. E., B. H. Iglewski, and W. G. Johanson. 1982. Host and bacterial factors in the colonization of the respiratory tract, p. 348-352. In D. Schlessinger (ed.), Microbiology - 1982. American Society for Microbiology, Washington, D.C.
489. Woods, D. E., P. A. Sokol, L. E. Bryan, D. G. Storey, S. J. Mattingly, H. J. Vogel, and H. Ceri. 1991. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J. Infect. Dis. 163:143-149.
490. Woods, D. E., D. C. Strauss, W. G. Johanson, Jr., V. K. Berry, and J. A. Bass. 1980. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect. Immun. 29:1146-1151.
491. Wozniak, D. J. 1994. Integration host factor and sequences downstream of the Pseudomonas aeruginosa algD transcription start site are required for expression. J. Bacteriol. 176:5068-5076.
492. Wozniak, D. J., and D. E. Ohman. 1991. Pseudomonas aeruginosa AlgB, a two-component response regulator of the NtrC family, is required for algD transcription. J. Bacteriol. 173:1406-1413.
493. Wozniak, D. J., and D. E. Ohman. 1994. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J. Bacteriol. 176:6007-6014.
494. Xiao, Y., S. Yeu, J. Yi, Y. Lu, and S. W. Hutcheson. 1994. Identification of putative alternate sigma factor and characterization of a multicomponent regulatory cascade controlling the expression of Pseudomonas syringae pv. syringae Pss61 hrp and hrmA genes. J. Bacteriol. 176:9754-9763.
495. Yabuuchi, E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hashimoto, T. Ezaki, and M. Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 36:1251-1275.
496. Ye, R. W., N. A. Zielinski, and A. M. Chakrabarty. 1994. Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide. J. Bacteriol. 176:4851-4857.
497. Yohalem, D. S., and J. W. Lorbeer. 1994. Multilocus isoenzyme diversity among strains of Pseudomonas cepacia isolated from decayed onions, soils, and clinical sources. Syst. Appl. Microbiol. 17:116-124.
498. Yoshimura, K., H. Nakamura, B. C. Trapnell, C.-S. Chu, W. Dalemans, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids. Res. 19:5417-5423.
499. E). Infect. Immun. 64:2774-2781.
500. Yu, H., J. C. Boucher, M. J. Schurr, M. Mudd, and V. Deretic. Unpublished results.
501. Yu, H., M. J. Schurr, J. C. Boucher, J. M. Martinez-Salazar, D. W. Martin, and V. Deretic. 1996. Molecular mechanism of conversion to mucoidy in Pseudomonas aeruginosa, p. 384-397. In S. Silver, T. Nakazawa, and D. Haas (ed.), Pseudomonas 95. American Society for Microbiology, Washington, D.C.
502. E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J. Bacteriol. 177:3259-3268.
503. Zar, H., L. Saiman, L. Quittell, and A. Prince. 1995. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J. Pediatr. 126: 230-233.
504. Zhou, L., C. R. Dey, S. E. Wert, M. D. DuVall, R. A. Frizzell, J. A. Whitsett. 1994. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266:1705-1708.
505. Zielinski, N., A. Chakrabarty, and A. Berry. 1991. Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J. Biol. Chem. 266:9754-9763.
506. Zielinski, N. A., R. Maharaj, S. Roychoudhury, C. E. Danganan, W. Hendrickson, and A. M. Chakrabarty. 1992. Alginate synthesis in Pseudomonas aeruginosa: environmental regulation of the algC promoter. J. Bacteriol. 174:7680-7688.